AsiaBiome was a headline speaker at the 2nd Microbiome Movement - Drug Development & Nutrition Asia Summit. Co-founder and CEO Jonathan Krive presented on Therapeutics Discovery through the Asian Gut Microbiome.
In his presentation, Mr Krive explained that the Asia gut microbiome is not homogeneous, but very heterogeneous, and unique from the gut microbiomes of many western countries. He also introduced the AsiaBiome proprietary live biotherapeutic drug discovery platform, including three lead candidates in IBS, autism, and type 2 diabetes.
For a copy of his presentation, please contact email@example.com